Loading
Latest filing published 21 Dec 2018 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.).
No signal scores available.
All filings by Roland Boivin on record concern Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). In total, 2 filings cover trades dated 19 December 2018.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 21 December 2018: a transaction, in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations